New Test Enhances DNA Reading for Rare Disorders

A new diagnostic approach using long-read genome sequencing can identify rare genetic disorders more effectively than current standard testing, potentially replacing fifteen separate diagnostic procedures. Researchers from Radboud University Medical Center, writing in the New England Journal of Medicine, recommend this method as the first-choice diagnostic tool for patients suspected of having rare genetic conditions, which affect fewer than one in two thousand people.

Did You Know? Long-read genome sequencing functions like a jigsaw puzzle; while standard tests read DNA in fragments of 300 building blocks, this new technology reads segments of up to 20,000 building blocks, allowing for a more accurate assembly of the genetic code.

How the New DNA Test Improves Diagnosis

The transition to long-read sequencing allows clinicians to gain a more comprehensive view of a patient’s DNA. According to Professor of Genome Bioinformatics Christian Gilissen, current diagnostic methods require additional specialized tests to detect modifications on the outside of the DNA that switch genes on or off. The new approach captures these modifications as a “bonus,” effectively performing two diagnostic functions at once.

In a study of one thousand patients conducted by researchers from Radboudumc and Maastricht UMC+, the new test yielded a three percent increase in confirmed diagnoses compared to standard diagnostics. Professor of Translational Genomics Lisenka Vissers stated that because the test is faster and more efficient, it is recommended for worldwide adoption as the primary diagnostic choice for rare genetic disorders.

Expert Insight: The clinical significance of this development lies in the reduction of the diagnostic odyssey for families. A definitive genetic diagnosis provides not only medical clarity but also psychological relief and actionable information for family planning, which is essential given that 80 percent of the seven thousand known rare diseases have a genetic origin.

Future Implications for Genomic Medicine

The capability to detect complex and hard-to-find genetic abnormalities is expected to grow as researchers link more findings to specific conditions. Professor of Genomic Technologies Alexander Hoischen noted that as knowledge of these abnormalities expands, the number of successful diagnoses will likely rise. The technology has already demonstrated practical utility, such as during a recent Undiagnosed Hackathon in Nijmegen, where specialists used the test to secure five new diagnoses for 33 participating families.

New genetic testing can identify more than 200 rare conditions in infants

Frequently Asked Questions

What defines a rare disease?
A condition is classified as rare if it affects fewer than one in two thousand people, though there are over seven thousand such types of diseases.

Why is a genetic diagnosis important for patients?
A diagnosis provides clarity, offers insight into the future, facilitates contact with others in similar situations, and allows families to assess risks when planning to have children.

How does this test differ from standard diagnostics?
Standard diagnostics often rely on multiple tests and read DNA in small fragments of 300 building blocks, whereas long-read sequencing reads segments of up to 20,000 building blocks and simultaneously identifies modifications that switch genes on or off.

Could the widespread adoption of this technology significantly shorten the time families wait for a rare disease diagnosis?